ClinVar Miner

Submissions for variant NM_000179.2(MSH6):c.3727A>T (p.Thr1243Ser) (rs147453999)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000115419 SCV000186076 uncertain significance Hereditary cancer-predisposing syndrome 2018-02-16 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence
Center for Human Genetics, Inc RCV000659895 SCV000781793 uncertain significance Hereditary nonpolyposis colorectal cancer type 5 2016-11-01 criteria provided, single submitter clinical testing
Color RCV000115419 SCV000685435 uncertain significance Hereditary cancer-predisposing syndrome 2018-08-22 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000212687 SCV000592654 uncertain significance not specified 2016-03-23 criteria provided, single submitter clinical testing
GeneDx RCV000588959 SCV000149328 uncertain significance not provided 2018-08-01 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.3727A>T at the cDNA level, p.Thr1243Ser (T1243S) at the protein level, and results in the change of a Threonine to a Serine (ACA>TCA). This variant has been observed in individuals with ovarian cancer or mesothelioma (Pal 2012, Betti 2017), and was detected by whole exome sequencing in an individual with developmental delay, autism, and some dysmorphic features, with no specific information about cancer history (Wang 2015). MSH6 Thr1243Ser was observed at an allele frequency of 0.1% (35/30,782) in individuals of South Asian ancestry in large population cohorts (Lek 2016). This variant is located in the ATPase domain (Warren 2007, Kansikas 2011). In silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Based on currently available evidence, it is unclear whether MSH6 Thr1243Ser is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
GeneKor MSA RCV000115419 SCV000822067 uncertain significance Hereditary cancer-predisposing syndrome 2018-08-01 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000122966 SCV000430979 uncertain significance Lynch syndrome 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000588959 SCV000695885 likely benign not provided 2016-07-18 criteria provided, single submitter clinical testing Variant summary: The MSH6 c.3727A>T (p.Thr1243Ser) variant causes a missense change involving a conserved nucleotide with 3/5 in silico tools predicting a "damaging" outcome, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 34/121216 (1/3565), predominantly in the South Asian cohort, 19/16504 (1/868), which exceeds the estimated maximal expected allele frequency for a pathogenic MSH6 variant of 1/7037. Therefore, suggesting that the variant is a common polymorphism found in population(s) of South Asian origin. A publication has cited the variant in an affected individual, although with limited information (ie, lack of co-occurrence or co-segregation). Multiple reputable databases/clinical laboratories cite the variant with conflicting classifications "uncertain significance" or "likely benign." Therefore, taking all available lines of evidence into consideration, the variant of interest has been classified as Likely Benign."
Invitae RCV000524186 SCV000166233 likely benign Hereditary nonpolyposis colon cancer 2017-12-18 criteria provided, single submitter clinical testing
PreventionGenetics RCV000588959 SCV000805896 uncertain significance not provided 2017-03-27 criteria provided, single submitter clinical testing
True Health Diagnostics RCV000115419 SCV000788052 uncertain significance Hereditary cancer-predisposing syndrome 2017-09-27 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.